CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Aerobic Exercise TrainingWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (3)

Name (Synonyms) Correlation
drug425 CAStem Wiki 1.00
drug2079 Respiratory Exercise Training Wiki 1.00
drug1769 Patient Education Wiki 1.00

Correlated MeSH Terms (7)

Name (Synonyms) Correlation
D055370 Lung Injury NIH 0.21
D011024 Pneumonia, Viral NIH 0.13
D013577 Syndrome NIH 0.11
D055371 Acute Lung Injury NIH 0.10
D012127 Respiratory Distress Syndrome, Newborn NIH 0.10
D012128 Respiratory Distress Syndrome, Adult NIH 0.09
D011014 Pneumonia NIH 0.06

Correlated HPO Terms (1)

Name (Synonyms) Correlation
HP:0002090 Pneumonia HPO 0.06

There is one clinical trial.

Clinical Trials

1 Telerehabilitation After Covid-19: Effectiveness of Respiratory and Aerobic Training

The aim of the study is to investigate the effects of telerehabilitation program on COVID-19 symptoms, quality of life, level of depression, perception of dyspnea, sleep, fatigue, kinesiophobia and patient satisfaction in individuals diagnosed with COVID-19.

NCT04473898 COVID Other: Aerobic Exercise Training Behavioral: Patient Education Other: Respiratory Exercise Training

Primary Outcomes

Description: It will be evaluated by the Modified Medical Research Council (mMRC). It consists of 5 items between 0 and 4. The increase in the score indicates the severity of dyspnea.

Measure: Dyspnoea

Time: baseline

Description: It will be evaluated by the Hospital Anxiety and Depression Scale (HADS). The questionnaire comprises seven questions for anxiety and seven questions for depression, and takes 2-5min to complete. Although the anxiety and depression questions are interspersed within the questionnaire, it is vital that these are scored separately. Cut-off scores are available for quantification, for example a score of 8 or more for anxiety. The increase in the score indicates the severity of anxiety and depression.

Measure: Anxiety and Depression

Time: baseline

Description: It will be evaluated by pittsburgh sleep quality index

Measure: Sleep Quality

Time: baseline

Description: It will be evaluated by SF-36

Measure: Health Related Quality of Life

Time: baseline

Description: It will be evaluated by the Modified Medical Research Council (mMRC). It will be evaluated by the Modified Medical Research Council (mMRC). It consists of 5 items between 0 and 4. The increase in the score indicates the severity of dyspnea.

Measure: Dyspnoea

Time: 6 weeks later

Description: It will be evaluated by the Hospital Anxiety and Depression Scale (HADS). The questionnaire comprises seven questions for anxiety and seven questions for depression, and takes 2-5min to complete. Although the anxiety and depression questions are interspersed within the questionnaire, it is vital that these are scored separately. Cut-off scores are available for quantification, for example a score of 8 or more for anxiety. The increase in the score indicates the severity of anxiety and depression.

Measure: Anxiety and Depression

Time: 6 weeks later

Description: It will be evaluated by pittsburgh sleep quality index

Measure: Sleep Quality

Time: 6 weeks later

Description: It will be evaluated by SF-36

Measure: Health Related Quality of Life

Time: 6 weeks later

Secondary Outcomes

Description: It will be evaluated by Kinesiophobia Causes Scale. The questionnaire consist of 20 closed questions, assessed in a range from 0 to 100 - a higher score indicating a higher fear of movement

Measure: Kinesiophobia

Time: baseline

Description: It will be evaluated by patient satisfaction scale. Likert scale questionnaire proposed seven dimensions of patient satisfaction directed toward their doctors. These are general satisfaction, technical quality, interpersonal manner, communication, financial aspects, time spent with doctor, and accessibility and convenience. Increased score indicates decreased satisfaction. The minimum score is 18, the maximum score is 90.

Measure: Patient Satisfaction

Time: 6 weeks later

Description: It will be evaluated by Fatigue Severity Scale. A self-report scale of nine items about fatigue, its severity and how it affects certain activities. Answers are scored on a seven point scale where 1 = strongly disagree and 7 = strongly agree. This means the minimum score possible is nine and the highest is 63.

Measure: Fatigue

Time: baseline

Description: It will be evaluated by Kinesiophobia Causes Scale. The questionnaire consist of 20 closed questions, assessed in a range from 0 to 100 - a higher score indicating a higher fear of movement

Measure: Kinesiophobia

Time: 6 weeks later

Description: It will be evaluated by Fatigue Severity Scale. A self-report scale of nine items about fatigue, its severity and how it affects certain activities. Answers are scored on a seven point scale where 1 = strongly disagree and 7 = strongly agree. This means the minimum score possible is nine and the highest is 63.

Measure: Fatigue

Time: 6 weeks later

No related HPO nodes (Using clinical trials)